Linked Life Data

19740658

Source:http://linkedlifedata.com/resource/pubmed/id/19740658

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2009-9-28
pubmed:abstractText
A second wave of potential SSRIs with high ease of synthetic accessibility were designed based on the reported selective serotonin re-uptake inhibitor litoxetine and our own previous work in this area. Preparation and subsequent optimisation yielded a range of potent and highly selective SSRIs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1464-3405
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5893-7
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
pubmed:affiliation
Discovery Chemistry, Pfizer Global Research and Development, Sandwich, United Kingdom.
pubmed:publicationType
Journal Article